| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/25/2009 | WO2009079401A2 Compositions and methods for increasing iron absorption |
| 06/25/2009 | WO2009079338A1 Treatment of melanoma with alpha thymosin peptides in combination with an antineoplastic heat shock apoptosis activator (hsaa) |
| 06/25/2009 | WO2009079220A2 Recombinant elastase proteins and methods of manufacturing and use thereof |
| 06/25/2009 | WO2009079007A1 Stem-like cells and method for reprogramming adult mammalian somatic cells |
| 06/25/2009 | WO2009078977A2 Compositions and methods to concurrently treat or prevent multiple diseases with cupredoxins |
| 06/25/2009 | WO2009078820A1 Cationic core-shell peptide nanoparticles |
| 06/25/2009 | WO2009078474A1 An agent for reducing a side effect of an anticancer drug |
| 06/25/2009 | WO2009077995A1 Cosmetic use of acid ceramidase type proteins |
| 06/25/2009 | WO2009077764A1 Compounds and methods for the treatment of vascular disease |
| 06/25/2009 | WO2009077731A2 Prolactin fusion proteins |
| 06/25/2009 | WO2009077570A1 Use of fzc18-containing collagen 18 polypeptides for the treatment, diagnosis and outcome prediction of diseases |
| 06/25/2009 | WO2009077401A1 Antitumoral compounds |
| 06/25/2009 | WO2009076966A2 Rhoc-based immunotherapy |
| 06/25/2009 | WO2009076711A1 Enzymes and methods for degrading chlorinated s-triazines |
| 06/25/2009 | WO2009076694A1 Treatment of inflammatory illnesses with ace2 |
| 06/25/2009 | WO2009060013A3 A method for treating ailments of the oral cavity with a krill enzyme composition |
| 06/25/2009 | WO2009053683A3 Treatment of inflammatory diseases |
| 06/25/2009 | WO2009050403A3 Patch with hydrophilic adhesive |
| 06/25/2009 | WO2009046875A3 Combination of splenopentin and thymopentin and the use thereof in medicine |
| 06/25/2009 | WO2009046863A3 Use of thymosin alpha 1 peptide or the combination with the human pancreatic polypeptide as a therapeutic agent |
| 06/25/2009 | WO2009042668A3 Urea-containing peptides as inhibitors of viral replication |
| 06/25/2009 | WO2009040046A3 Use of stresscopin-related peptide as a therapeutic agent |
| 06/25/2009 | WO2009040021A3 Use of a peptide as a therapeutic agent |
| 06/25/2009 | WO2009034041A3 Peptide sequences and compositions |
| 06/25/2009 | WO2009033746A3 Use of a peptide as a therapeutic agent |
| 06/25/2009 | WO2009026393A3 Amino acid substituted molecules |
| 06/25/2009 | WO2009025760A3 Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof |
| 06/25/2009 | WO2009022907A3 A method for identifying, expanding, and removing adult stem cells and cancer stem cells |
| 06/25/2009 | WO2009010733A3 Peptide gap junction modulators |
| 06/25/2009 | WO2009007848A3 Bioactive peptides and method of using same |
| 06/25/2009 | WO2008152527A3 Cell-proliferation inhibiting vpg proteins, fragments or analogs thereof and their applications. |
| 06/25/2009 | WO2008097497A3 Vegf pathway blockade |
| 06/25/2009 | WO2006029046A3 Use of leptin in wound healing |
| 06/25/2009 | WO2005110461A3 Leptin peptide antagonists |
| 06/25/2009 | WO2005032482A3 Treatment of demyelinating autoimmune disease with modified ordered peptides |
| 06/25/2009 | US20090163895 Implantable device for controlled, extended delivery of parathyroid hormone |
| 06/25/2009 | US20090163844 Methods for the treatment or prevention of scars and/or keloids |
| 06/25/2009 | US20090163530 adapted to adhere to and dissolve in a mouth of a consumer include a water soluble film-forming polymer pullulan, antimicrobially effective amounts of essential oils thymol, methyl salicylate, eucalyptol and menthol; for killing plaque-producing germs that cause dental plaque, bad breath, gingivitis |
| 06/25/2009 | US20090163436 Methods for delivery of nucleic acids |
| 06/25/2009 | US20090163429 Rna aptamers and methods for identifying the same |
| 06/25/2009 | US20090163426 Prostate specific antigen; immobilization; antiproliferative agents; drug delivery; contain cleavage sites specifically cleaved by prostate specific membrane antigen (PSMA); useful for substantially inhibiting the non-specific toxicity of a variety of therapeutic drugs |
| 06/25/2009 | US20090163425 Peptide Inhibiting Angiotensin Converting Enzyme |
| 06/25/2009 | US20090163424 Soluble tumor necrosis factor receptor treatment of medical disorders |
| 06/25/2009 | US20090163423 Exendins and Exendin Agonist Analogs to Regulate Gastrointestinal Motility |
| 06/25/2009 | US20090163422 Three-dimensional structure of the apobec 2 structure, uses thereof, and methods for treating chronic and infectious diseases |
| 06/25/2009 | US20090163421 Room Temperature Stable, Lyophilized Natriuretic Peptide Formulations |
| 06/25/2009 | US20090163420 Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid beta, prion protein, amylin, alpha-synuclein, or polyglutamine repeats for induction of an immune response thereto |
| 06/25/2009 | US20090163419 Human growth hormone aqueous formulation |
| 06/25/2009 | US20090163418 Resuscitation fluid |
| 06/25/2009 | US20090163417 Activin-actrii antagonists and uses for increasing red blood cell levels |
| 06/25/2009 | US20090163416 Use of a ghrelin agonist to improve the catabolic effects of glucocorticoid treatment |
| 06/25/2009 | US20090163415 NT-proBNP, proBNP AND BNP IMMUNOASSAYS, ANTIBODIES AND STABLE STANDARD |
| 06/25/2009 | US20090163414 In-vitro method for screening accessible biological markers in pathological tissues |
| 06/25/2009 | US20090163413 Dental products comprising bone growth enhancing peptide |
| 06/25/2009 | US20090163412 Compositions and Methods of Topical Application and Transdermal Delivery of Botulinum Toxins with Reduced Non-Toxin Proteins |
| 06/25/2009 | US20090163411 Long acting vegf inhibitors and methods of use |
| 06/25/2009 | US20090163410 Novel Peptides and the Biological Use Thereof |
| 06/25/2009 | US20090163409 Trappin-2 (elafin) inhibits HIV |
| 06/25/2009 | US20090163408 Salicylanilides enhance oral delivery of therapeutic peptides |
| 06/25/2009 | US20090163407 Compositions and methods for altering wnt autocrine signaling |
| 06/25/2009 | US20090163406 Compositions and methods for diagnosing and treating brain cancer and identifying neural stem cells |
| 06/25/2009 | US20090163405 Angiogenic peptides and uses thereof |
| 06/25/2009 | US20090162873 Gene encoding a multidrug-resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
| 06/25/2009 | US20090162850 Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer |
| 06/25/2009 | US20090162454 Compositions and Methods for Effecting NAD+ Levels Using A Nicotinamide Phosphoribosyl Tranferase Inhibitor |
| 06/25/2009 | US20090162437 Modified self-assembling peptides |
| 06/25/2009 | US20090162429 Slow-Release Composition, Method for the Preparation Thereof, and Use Thereof |
| 06/25/2009 | US20090162427 Vaccines using nucleic acid-lipid complexes |
| 06/25/2009 | US20090162426 Use of a Compound with RANKL Activity |
| 06/25/2009 | US20090162423 Formulations for cosmetic and wound care treatments with photosensitizes as fluorescent markers |
| 06/25/2009 | US20090162404 Tumor vaccine |
| 06/25/2009 | US20090162402 Immunizing compositions and methods of use |
| 06/25/2009 | US20090162383 Method for designing vaccines against constantly mutating pathogens |
| 06/25/2009 | US20090162379 Inhibitors of S. aureus SdrD protein attachment to cells and uses therefor |
| 06/25/2009 | US20090162368 Mechanosensitive mammalian potassium channel activatable by polyunsaturated fatty acids |
| 06/25/2009 | US20090162367 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 06/25/2009 | US20090162364 Apo-2 ligand |
| 06/25/2009 | US20090162363 Pedf-r receptor and uses |
| 06/25/2009 | US20090162357 Diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases |
| 06/25/2009 | US20090162354 Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage |
| 06/25/2009 | US20090162350 Novel composition and methods for the treatment of immune related disease |
| 06/25/2009 | US20090162349 Method for prevention or treatment of diseases or disorders related to excessive formation of vascular tissue or blood vessels |
| 06/25/2009 | US20090162347 Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 06/25/2009 | US20090162343 Recombinant elastase proteins and methods of manufacturing and use thereof |
| 06/25/2009 | US20090162342 Therapeutic uses of glandular kallikrein |
| 06/25/2009 | US20090162341 For inhibition or reduction of exocytic fusion in a nociceptive sensory afferent cell comprising a Targeting Moiety, a non-cytotoxic protease and a Translocation Domain; pain |
| 06/25/2009 | US20090162340 Stable galenic freeze-dried pharmaceutical preparation of recombinant carbohydrate-binding polypeptides |
| 06/25/2009 | US20090162339 drug delivery of an enzyme such as erythromycin esterase or beta-lactamase capable of deactivating a beta -lactam, macrolide, or quinolone antibiotic; reducing the concentration of an antibiotic in the colon; ulcerative colitis or Crohn's disease |
| 06/25/2009 | US20090162338 Inhibiting metastasis of cancer cells by administering a phosphatidyl inositol 3-kinase inhibitor such as Wortmannin or LY294002 (2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one) |
| 06/25/2009 | US20090162337 Embedded enzymes in polymers to regulate their degradation rate |
| 06/25/2009 | US20090162336 Novel Tools for the Diagnosis and Treatment of Alzheimer's Disease |
| 06/25/2009 | US20090162335 Melatonin and immunostimulating substance-based compositions |
| 06/25/2009 | US20090162333 Pharmaceutical composition comprising apolipoproteins for the treatment of human diseases |
| 06/25/2009 | US20090162319 Reverse transcriptase inhibitors |
| 06/25/2009 | US20090162318 Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors |
| 06/25/2009 | US20090162317 Polynucleotide encoding HCV epitopes which can bind to various HLA supertypes, immunogenic composition comprising same and method of inducing an HCV-specific immune response using same |
| 06/25/2009 | US20090162316 Liver targeted conjugates |
| 06/25/2009 | US20090162315 Enterotoxin gene cluster (egc) superantigens to treat malignant disease |
| 06/25/2009 | US20090162296 Approach to treat intraocular hypertension |
| 06/25/2009 | US20090162286 Phosphodiesterase 10 Inhibition as Treatment for Obesity-Related and Metabolic Syndrome-Related Conditions |